Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy

BACKGROUND: The gut microbiome is associated with the response to immunotherapy in a variety of advanced cancers. However, the influence of the gut microbiome on locally advanced esophageal squamous cell carcinoma (ESCC) during programmed cell death protein 1 (PD-1) antibody immunotherapy plus chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liwei, Qi, Yajun, Jiang, Youhua, Ji, Yongling, Zhao, Qiang, Wu, Jie, Lu, Weishan, Wang, Yinjie, Chen, Qixun, Wang, Changchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011252/
https://www.ncbi.nlm.nih.gov/pubmed/35433940
http://dx.doi.org/10.21037/atm-22-1165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011252/
https://www.ncbi.nlm.nih.gov/pubmed/35433940
http://dx.doi.org/10.21037/atm-22-1165

Ejemplares similares